BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12214070)

  • 21. Structural basis of dementia in neurodegenerative disorders.
    Jellinger KA
    J Neural Transm Suppl; 1996; 47():1-29. PubMed ID: 8841954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avoidance of Apoptosis in Alzheimer's Disease.
    Nunomura A; Chiba S
    J Alzheimers Dis; 2000 Mar; 2(1):59-60. PubMed ID: 12214111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ.
    Lassmann H; Bancher C; Breitschopf H; Wegiel J; Bobinski M; Jellinger K; Wisniewski HM
    Acta Neuropathol; 1995; 89(1):35-41. PubMed ID: 7709729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.
    Yan T; Wang L; Gao J; Siedlak SL; Huntley ML; Termsarasab P; Perry G; Chen SG; Wang X
    J Alzheimers Dis; 2018; 63(1):157-165. PubMed ID: 29562525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in neuronal apoptosis.
    Jellinger KA
    Curr Alzheimer Res; 2006 Sep; 3(4):377-91. PubMed ID: 17017868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology.
    Su JH; Deng G; Cotman CW
    J Neuropathol Exp Neurol; 1997 Jan; 56(1):86-93. PubMed ID: 8990132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies.
    Broe M; Shepherd CE; Milward EA; Halliday GM
    Acta Neuropathol; 2001 Jun; 101(6):616-24. PubMed ID: 11515791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hunt for dying neurons: insight into the neuronal loss in Alzheimer's disease.
    Zilkova M; Koson P; Zilka N
    Bratisl Lek Listy; 2006; 107(9-10):366-73. PubMed ID: 17262989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia.
    Su JH; Nichol KE; Sitch T; Sheu P; Chubb C; Miller BL; Tomaselli KJ; Kim RC; Cotman CW
    Exp Neurol; 2000 May; 163(1):9-19. PubMed ID: 10785439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies.
    Leigh PN; Probst A; Dale GE; Power DP; Brion JP; Dodson A; Anderton BH
    Acta Neuropathol; 1989; 79(1):61-72. PubMed ID: 2555999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].
    Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal and glial DNA fragmentation in Pick's disease.
    Gleckman AM; Jiang Z; Liu Y; Smith TW
    Acta Neuropathol; 1999 Jul; 98(1):55-61. PubMed ID: 10412801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
    Banati RB; Daniel SE; Blunt SB
    Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease.
    Selznick LA; Holtzman DM; Han BH; Gökden M; Srinivasan AN; Johnson EM; Roth KA
    J Neuropathol Exp Neurol; 1999 Sep; 58(9):1020-6. PubMed ID: 10499444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
    Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
    Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.